Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Purple Biotech Ltd.

    NASDAQ: PPBT · Real-Time Price · USD
    2.41
    -0.05 (-2.03%)
    At close: Jun 13, 2025, 3:47 PM
    2.45
    1.66%
    After-hours: Jun 13, 2025, 04:00 PM EDT

    Purple Biotech Statistics

    Share Statistics

    Purple Biotech has 2.65M shares outstanding. The number of shares has increased by -5.97% in one year.

    Shares Outstanding

    n/a
    		 2.65M

    Shares Change (YoY)

    n/a
    		 -5.97%

    Shares Change (QoQ)

    n/a
    		 2.53%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 2.65M

    Failed to Deliver (FTD) Shares

    n/a
    		 366

    FTD / Avg. Volume

    n/a
    		 0.35%

    Short Selling Information

    The latest short interest is 165.7K, so 6.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 165.7K

    Short % of Shares Out

    n/a
    		 6.26%

    Short % of Float

    n/a
    		 6.43%

    Short Ratio (days to cover)

    n/a
    		 6.38

    Valuation Ratios

    The PE ratio is -0.1 and the forward PE ratio is -3.98. Purple Biotech's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.1

    Forward PE

    n/a
    		 -3.98

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.02

    P/FCF Ratio

    n/a
    		 -0.05

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Purple Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 2.23

    Quick Ratio

    n/a
    		 2.23

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -268.41

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-804,444.44

    Employee Count

    n/a
    		 9

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -79.95% in the last 52 weeks. The beta is -0.74, so Purple Biotech's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.74

    52-Week Price Change

    n/a
    		 -79.95%

    50-Day Moving Average

    n/a
    		 2.49

    200-Day Moving Average

    n/a
    		 3.75

    Relative Strength Index (RSI)

    n/a
    		 46.38

    Average Volume (20 Days)

    n/a
    		 105,439

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -11.01M

    Net Income

    n/a
    		 -7.24M

    EBITDA

    n/a
    		 -7.05M

    EBIT

    n/a
    		 -7.24M

    Earnings Per Share (EPS)

    n/a
    		 -0.03
    Full Income Statement

    Balance Sheet

    The company has 7.4M in cash and 183K in debt, giving a net cash position of 7.22M.

    Cash & Cash Equivalents

    n/a
    		 7.4M

    Total Debt

    n/a
    		 183K

    Net Cash

    n/a
    		 7.22M

    Retained Earnings

    n/a
    		 -144.69M

    Total Assets

    n/a
    		 37.04M

    Working Capital

    n/a
    		 4.92M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.37M and capital expenditures 0, giving a free cash flow of -14.37M.

    Operating Cash Flow

    n/a
    		 -14.37M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -14.37M

    FCF Per Share

    n/a
    		 -0.41
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PPBT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PPBT is $33, which is 1269.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $33

    Price Target Difference

    n/a
    		 1269.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 17, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Sep 17, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -5.95

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist